InvestorsHub Logo
Followers 118
Posts 18914
Boards Moderated 0
Alias Born 08/27/2005

Re: KravMD post# 204342

Friday, 06/10/2016 12:54:33 PM

Friday, June 10, 2016 12:54:33 PM

Post# of 401408
Uncertainty was evident during the meeting as different doctors
offered their comments.

The one aspect I took away from this is that something is very much needed to stem the prescription opioid abuse. Many of those doctors
although somewhat negative more or less admitted that it was better than what was currently available.

Elite's ADF for extended release has better deterrent properties than ALO-02.
So with the recommendation from this advisory board it looks as though ALO-02 will get approval and partial ADT labeling.

Good for Elite. Look for an NDA submission by Elite soon after ALO-02 approval by the FDA. Just my opinion.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News